The Global Enzyme Linked Immunosorbent Assay Market Growth Accelerated By Increasing Prevalence Of Chronic Diseases

 

Enzyme Linked Immunosorbent Assay Market 

Enzyme Linked Immunosorbent Assay or ELISA plays a crucial role in detecting various chronic diseases. It is a biochemical technique used mainly in immunology to detect the presence of antibodies and antigens in samples like blood, serum and plasma. ELISA technique offers high sensitivity and specificity for detecting diseases at an early stage. The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Increasing prevalence of chronic diseases like cancer, cardiovascular diseases, diabetes and infectious diseases are the major factors fueling the growth of the ELISA market. According to the estimates of WHO, chronic diseases accounted for around 70% of all deaths worldwide in 2020. Moreover, adoption of sedentary lifestyle and consumption of junk food has also contributed significantly towards the rising cases of chronic illnesses.ELISA technique plays a pivotal role in early detection of such diseases which can help in timely treatment. Technological advancements in ELISA platforms have enabled development of high-throughput automated system with improved sensitivity, specificity and reproducibility. This has expanded the applications of ELISA in different clinical diagnostic areas thus driving the market growth over the forecast period.

Segment Analysis

The global enzyme linked immunosorbent assay market is dominated by sandwich ELISA segment which accounted for around 60% share in 2022. Sandwich ELISA is widely used technique which detects antibodies or proteins in the sample. In sandwich ELISA, two antibodies are used- one to capture the antigen onto the surface and other linked to an enzyme to detect the bound antigen. This technique offers high specificity and sensitivity for detection of various biomolecules and hence is the most commonly used ELISA technique globally.

Key Takeaways

The global enzyme linked immunosorbent assay market demand is expected to witness high growth over the forecast period. The market growth can be attributed to factors such as increasing prevalence of chronic and infectious diseases globally, rising research activities in life science industry and growing demand for diagnostic testing. The global Enzyme Linked Immunosorbent Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030.

Regional analysis
North America dominated the global market and accounted for over 35% market share in 2022 due to increasing research funding, advanced healthcare infrastructure and presence of leading market players in the region. Asia Pacific is expected to witness fastest growth during the forecast period attributed to growing healthcare expenditure, rising geriatric population, expanding biopharmaceutical industry and increasing awareness.

Key players
Key players operating in the enzyme linked immunosorbent assay market are Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Get more insights on this topic: https://www.newswirestats.com/enzyme-linked-immunosorbent-assay-market-industry-insights-trendsenzyme-linked-immunosorbent-assay-market-2023-2030/

Comments

Popular posts from this blog

Increasing aircrafts deliveries to fuel the growth of Aircraft Radome Market

The Global Cryocooler Market Growth Accelerated By Rising Demand From Aerospace And Military Industries

The Global Dutch Brick Market Growth Accelerated By Increase In Residential Construction